339 related articles for article (PubMed ID: 24468312)
21. Current treatment of peripheral T-cell lymphoma.
Horwitz SM; Coiffier B; Hsi ED; Pro B
Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.
Paolo C; Lucia F; Anna D
Leuk Lymphoma; 2007 Aug; 48(8):1496-501. PubMed ID: 17701579
[TBL] [Abstract][Full Text] [Related]
23. Current management of peripheral T-cell lymphomas.
Gooptu M; Rhoades R; Pro B
Cancer Treat Res; 2015; 165():289-303. PubMed ID: 25655615
[TBL] [Abstract][Full Text] [Related]
24. Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphoma.
Van de Wyngaert Z; Coppo P; Cervera P; Fabiani B; Lemonnier MP; Corre E; Marjanovic Z; Aoudjhane M; Mohty M; Duléry R
Eur J Haematol; 2021 Apr; 106(4):467-472. PubMed ID: 33320379
[TBL] [Abstract][Full Text] [Related]
25. Frontline Management of Nodal Peripheral T-Cell Lymphomas.
Ngu HS; Savage KJ
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390334. PubMed ID: 37262395
[TBL] [Abstract][Full Text] [Related]
26. Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial.
Park BB; Kim WS; Suh C; Shin DY; Kim JA; Kim HG; Lee WS
Ann Hematol; 2015 Nov; 94(11):1845-51. PubMed ID: 26251158
[TBL] [Abstract][Full Text] [Related]
27. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
28. Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL).
Zhang JY; Briski R; Devata S; Kaminski MS; Phillips TJ; Mayer TL; Bailey NG; Wilcox RA
Am J Hematol; 2018 Mar; 93(3):394-400. PubMed ID: 29194714
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Advani RH; Ansell SM; Lechowicz MJ; Beaven AW; Loberiza F; Carson KR; Evens AM; Foss F; Horwitz S; Pro B; Pinter-Brown LC; Smith SM; Shustov AR; Savage KJ; Vose JM
Br J Haematol; 2016 Feb; 172(4):535-44. PubMed ID: 26627450
[TBL] [Abstract][Full Text] [Related]
30. Peripheral T-cell lymphoma--not otherwise specified.
Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
[TBL] [Abstract][Full Text] [Related]
31. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
[TBL] [Abstract][Full Text] [Related]
32. [Current treatment strategies for peripheral T-cell lymphoma].
Munakata W
Rinsho Ketsueki; 2021; 62(8):1112-1120. PubMed ID: 34497198
[TBL] [Abstract][Full Text] [Related]
33. Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.
Sharma M; Pro B
Curr Treat Options Oncol; 2015 Jul; 16(7):34. PubMed ID: 26076798
[TBL] [Abstract][Full Text] [Related]
34. High-dose therapy and stem cell transplantation.
Zinzani PL
Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
[TBL] [Abstract][Full Text] [Related]
35. How to select the frontline treatment for a patient with peripheral T-cell lymphoma.
Ansell S
Leuk Lymphoma; 2016; 57(4):783-8. PubMed ID: 26850659
[TBL] [Abstract][Full Text] [Related]
36. Therapies for peripheral T-cell lymphomas.
Savage KJ
Hematology Am Soc Hematol Educ Program; 2011; 2011():515-24. PubMed ID: 22160083
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
Majhail NS; Burns LJ
Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
[TBL] [Abstract][Full Text] [Related]
38. The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience.
Rohlfing S; Dietrich S; Witzens-Harig M; Hegenbart U; Schönland S; Luft T; Ho AD; Dreger P
Ann Hematol; 2018 Jul; 97(7):1241-1250. PubMed ID: 29549411
[TBL] [Abstract][Full Text] [Related]
39. A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.
Mehta N; Maragulia JC; Moskowitz A; Hamlin PA; Lunning MA; Moskowitz CH; Zelenetz A; Matasar MJ; Sauter C; Goldberg J; Horwitz SM
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):664-70. PubMed ID: 24035712
[TBL] [Abstract][Full Text] [Related]
40. New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma.
Merli M; Ferrario A; Maffioli M; Olivares C; Stasia A; Arcaini L; Passamonti F
Expert Rev Hematol; 2016 Aug; 9(8):767-80. PubMed ID: 27416486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
